Search results
Results from the WOW.Com Content Network
Diclofenac is a topical NSAID. It has a clear benefit over traditional NSAIDs in that topical application reduces the amount of drug circulating systemically, and therefore reduces the risk of negative side effects. Diclofenac has been shown to reduce lameness secondary to joint pain in horses. [26]
Pain is the most common cause of lameness in the horse. [2] It is usually the result of trauma or orthopedic disease, but other causes such as metabolic dysfunction, circulatory disease, and infection can also cause pain and subsequent lameness.
Isoxsuprine (used as isoxsuprine hydrochloride) is a drug used as a vasodilator [4] in humans (under the trade name Duvadilan) and equines. Isoxsuprine is a β 2 adrenoreceptor agonist that causes direct relaxation of uterine and vascular smooth muscle via β 2 receptors .
A horse can live with laminitis for many years, and although a single episode of laminitis predisposes to further episodes, with good management and prompt treatment it is by no means the catastrophe sometimes supposed: most horses suffering an acute episode without pedal bone displacement make a complete functional recovery. Some ...
Horse ointment, known as horse oil and horse fat, is a topical formulation derived from subcutaneous fat of horses. [1] Due to its thickness and viscosity , horse ointment is intended for topical use on human skin and mucous membranes to moisturize and increase the restoration of damaged skin.
The topical cream can be used to relieve back pain, minor arthritis and muscle and joint pain. A 4-ounce tube retails for around $8 so it's pretty affordable, plus, it has great reviews.
Pituitary pars intermedia dysfunction (PPID), or equine Cushing's disease, is an endocrine disease affecting the pituitary gland of horses. It is most commonly seen in older animals, [ 1 ] and is classically associated with the formation of a long, wavy coat ( hirsutism ) and chronic laminitis .
Zycosan, for horses, is a heparin-like compound and is the first injectable pentosan product to receive approval by the US Food and Drug Administration (FDA). [ 21 ] In December 2022, the US Food and Drug Administration (FDA) approved pentosan polysulfate (Zycosan) for the control of clinical signs associated with osteoarthritis in horses. [ 21 ]